Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment: A Randomized Controlled Trial

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{d1c482e42aca4cd79d343a3c3c0fb516,
title = "Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment: A Randomized Controlled Trial",
abstract = "CONTEXT: Patients with colorectal cancer have increased risk of metabolic diseases including diabetes. Exercise training may counteract metabolic dysregulation, but the impact of exercise training on glycemic control, including postprandial glycemia, has never been explored in patients with colorectal cancer.OBJECTIVE: To examine the effects of home-based interval walking on aerobic and metabolic fitness and quality of life in patients with colorectal cancer.DESIGN: Randomized controlled trial.SETTING: Clinical research center.PARTICIPANTS: Thirty-nine sedentary (<150 minutes moderate-intensity exercise per week) patients with stage I to III colorectal cancer who had completed primary treatment.INTERVENTION: Home-based interval walking 150 min/wk or usual care for 12 weeks.MAIN OUTCOME MEASURES: Changes from baseline to week 12 in maximum oxygen uptake (VO2peak) by cardiopulmonary exercise test, glycemic control by oral glucose tolerance test (OGTT), body composition by dual-energy x-ray absorptiometry scan, blood biochemistry, and quality of life.RESULTS: Compared with control, interval walking had no effect on VO2peak [mean between-group difference: -0.32 mL O2 · kg-1 · min-1 (-2.09 to 1.45); P = 0.721] but significantly improved postprandial glycemic control with lower glucose OGTT area under the curve [-126 mM · min (-219 to -33); P = 0.009], 2-hour glucose concentration [-1.1 mM (-2.2 to 0.0); P = 0.056], and improved Matsuda index [1.94 (0.34; 3.54); P = 0.01]. Also, interval walking counteracted an increase in fat mass in the control group [-1.47 kg (-2.74 to -0.19); P = 0.025].CONCLUSION: A home-based interval-walking program led to substantial improvements in postprandial glycemic control and counteracted fat gain in posttreatment patients with colorectal cancer, possibly providing an effective strategy for prevention of secondary metabolic diseases.",
author = "Christensen, {Jesper F} and Anna Sundberg and Jens Osterkamp and Sarah Thorsen-Streit and Nielsen, {Anette B} and Olsen, {Cecilie K} and Djurhuus, {Sissal S} and Casper Simonsen and Tim Schauer and Helga Ellingsgaard and Kell {\O}sterlind and Peter-Martin Krarup and Camilla Mosgaard and Kirsten Vistisen and Anders Tolver and Pedersen, {Bente K} and Pernille Hojman",
note = "Copyright {\textcopyright} 2019 Endocrine Society.",
year = "2019",
month = sep,
day = "1",
doi = "10.1210/jc.2019-00590",
language = "English",
volume = "104",
pages = "3701--3712",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The/Endocrine Society",
number = "9",

}

RIS

TY - JOUR

T1 - Interval Walking Improves Glycemic Control and Body Composition After Cancer Treatment

T2 - A Randomized Controlled Trial

AU - Christensen, Jesper F

AU - Sundberg, Anna

AU - Osterkamp, Jens

AU - Thorsen-Streit, Sarah

AU - Nielsen, Anette B

AU - Olsen, Cecilie K

AU - Djurhuus, Sissal S

AU - Simonsen, Casper

AU - Schauer, Tim

AU - Ellingsgaard, Helga

AU - Østerlind, Kell

AU - Krarup, Peter-Martin

AU - Mosgaard, Camilla

AU - Vistisen, Kirsten

AU - Tolver, Anders

AU - Pedersen, Bente K

AU - Hojman, Pernille

N1 - Copyright © 2019 Endocrine Society.

PY - 2019/9/1

Y1 - 2019/9/1

N2 - CONTEXT: Patients with colorectal cancer have increased risk of metabolic diseases including diabetes. Exercise training may counteract metabolic dysregulation, but the impact of exercise training on glycemic control, including postprandial glycemia, has never been explored in patients with colorectal cancer.OBJECTIVE: To examine the effects of home-based interval walking on aerobic and metabolic fitness and quality of life in patients with colorectal cancer.DESIGN: Randomized controlled trial.SETTING: Clinical research center.PARTICIPANTS: Thirty-nine sedentary (<150 minutes moderate-intensity exercise per week) patients with stage I to III colorectal cancer who had completed primary treatment.INTERVENTION: Home-based interval walking 150 min/wk or usual care for 12 weeks.MAIN OUTCOME MEASURES: Changes from baseline to week 12 in maximum oxygen uptake (VO2peak) by cardiopulmonary exercise test, glycemic control by oral glucose tolerance test (OGTT), body composition by dual-energy x-ray absorptiometry scan, blood biochemistry, and quality of life.RESULTS: Compared with control, interval walking had no effect on VO2peak [mean between-group difference: -0.32 mL O2 · kg-1 · min-1 (-2.09 to 1.45); P = 0.721] but significantly improved postprandial glycemic control with lower glucose OGTT area under the curve [-126 mM · min (-219 to -33); P = 0.009], 2-hour glucose concentration [-1.1 mM (-2.2 to 0.0); P = 0.056], and improved Matsuda index [1.94 (0.34; 3.54); P = 0.01]. Also, interval walking counteracted an increase in fat mass in the control group [-1.47 kg (-2.74 to -0.19); P = 0.025].CONCLUSION: A home-based interval-walking program led to substantial improvements in postprandial glycemic control and counteracted fat gain in posttreatment patients with colorectal cancer, possibly providing an effective strategy for prevention of secondary metabolic diseases.

AB - CONTEXT: Patients with colorectal cancer have increased risk of metabolic diseases including diabetes. Exercise training may counteract metabolic dysregulation, but the impact of exercise training on glycemic control, including postprandial glycemia, has never been explored in patients with colorectal cancer.OBJECTIVE: To examine the effects of home-based interval walking on aerobic and metabolic fitness and quality of life in patients with colorectal cancer.DESIGN: Randomized controlled trial.SETTING: Clinical research center.PARTICIPANTS: Thirty-nine sedentary (<150 minutes moderate-intensity exercise per week) patients with stage I to III colorectal cancer who had completed primary treatment.INTERVENTION: Home-based interval walking 150 min/wk or usual care for 12 weeks.MAIN OUTCOME MEASURES: Changes from baseline to week 12 in maximum oxygen uptake (VO2peak) by cardiopulmonary exercise test, glycemic control by oral glucose tolerance test (OGTT), body composition by dual-energy x-ray absorptiometry scan, blood biochemistry, and quality of life.RESULTS: Compared with control, interval walking had no effect on VO2peak [mean between-group difference: -0.32 mL O2 · kg-1 · min-1 (-2.09 to 1.45); P = 0.721] but significantly improved postprandial glycemic control with lower glucose OGTT area under the curve [-126 mM · min (-219 to -33); P = 0.009], 2-hour glucose concentration [-1.1 mM (-2.2 to 0.0); P = 0.056], and improved Matsuda index [1.94 (0.34; 3.54); P = 0.01]. Also, interval walking counteracted an increase in fat mass in the control group [-1.47 kg (-2.74 to -0.19); P = 0.025].CONCLUSION: A home-based interval-walking program led to substantial improvements in postprandial glycemic control and counteracted fat gain in posttreatment patients with colorectal cancer, possibly providing an effective strategy for prevention of secondary metabolic diseases.

U2 - 10.1210/jc.2019-00590

DO - 10.1210/jc.2019-00590

M3 - Journal article

C2 - 31220283

VL - 104

SP - 3701

EP - 3712

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -

ID: 58656409